Pratiba Irudayaraj Top !!hot!! Jun 2026

: Irudayaraj's collaborations have investigated the role of the Nucleocapsid (N) protein in the innate immune processes of host cells, contributing to a deeper understanding of how viruses evade human immune responses [18]. Academic & Professional Background

Pratiba Irudayaraj is a researcher specializing in and biotechnology , particularly known for her work on SARS-CoV-2 (COVID-19) and biosensor technology . She is currently affiliated with GeneOne Life Science, Inc., as indicated on her professional profile [5]. Research Contributions

Ensure your primary professional site cleanly lists your top achievements right at the header.

The professional profile of Pratiba Irudayaraj extends further, placing her among the top-tier researchers who contributed to the global fight against COVID-19. Her name appears as a co-author on the seminal paper, "An overview of SARS-CoV-2 viral proteins with relevance to improved diagnostic and therapeutic platforms".. pratiba irudayaraj top

Following her academic tenure, Irudayaraj transitioned into professional roles as a scientific researcher, bridging the gap between theoretical laboratory work and real-world clinical assets. Her research involvement extends internationally, finding alignment with forward-thinking pharmaceutical and biotechnology enterprises like GeneOne Life Science, Inc. based in Seoul, Republic of Korea. Key Research Benchmarks & Publications

The design relies on dually labeled magnetic nanobeads deployed directly inside a microfluidic chip. This approach achieves dual outcomes:

By altering the underlying surface chemistry, Irudayaraj and her research partners adapted this platform into a ultra-portable, . The handheld variant maintains a clinical-grade validation threshold of 230 pg/mL in raw whole serum—enabling laboratory-grade molecular screening directly at remote clinics, airports, or standard points of care. Translational Virology and Therapeutic Horizons : Irudayaraj's collaborations have investigated the role of

Enabling rapid, on-site screening without the need for centralized laboratory infrastructure. Validation with Clinical Specimens

Irudayaraj was involved in creating a unique immunosensor utilizing dually-labeled magnetic nanobeads (DMBs). This technology allows for rapid (

Her more recent work explores next-generation treatments that move beyond traditional options. Pratiba Irudayaraj - Loop (Frontiers) or standard points of care.

The Evolution of Rapid Diagnostics: Exploring the Contributions of Pratiba Irudayaraj

, where she earned a Master’s degree in Bioengineering (2016–2018). Academic Contributions: During her time at UPenn, she served as a Graduate Research Assistant

: Irudayaraj frequently collaborates with experts from institutions like The Wistar Institute and New York University (NYU) Langone Health , demonstrating her role in high-level scientific partnerships. Leadership and Global Impact